Comparison of the Efficacy of Transurethral Enucleation and Resection of the Prostate with Transurethral Resection of the Prostate for Medium Prostate Sizes

2020 ◽  
Vol 103 (11) ◽  
pp. 1208-1213
Keyword(s):  
Transurethral Resection ◽  
Controlled Trial ◽  
Length Of Hospital Stay ◽  
Average Weight ◽  
Intraoperative Bleeding ◽  
Tissue Removal ◽  
Prospective Randomized Controlled Trial ◽  
The Mean ◽  
Baseline Characteristics ◽  
One Year

Objective: To compare the efficacy of the transurethral enucleation of the prostate (TUERP) to transurethral resection of the prostate (TURP) through a prospective randomized controlled trial. Materials and Methods: Between January 2016 and December 2019, 46 patients from a single center were divided into two groups, TURP and TUERP, using simple randomization. The perioperative and postoperative outcomes up to one year after surgery were evaluated. Results: The mean estimated prostate volume (PV) in the TURP and TUERP group was 40±22 mL and 41±18 mL, respectively. There were no statistical differences in the baseline characteristics between the two groups. The mean operative time was significantly longer in the TUERP group (71.95±33.96 minutes versus 50.85±26.78 minutes; p=0.024). The average weight of prostate resected in the TUERP group was higher but not statistically significant (18.87±14.95 g versus 15.15±11.07 g; p=0.39). The volume of fluid irrigation collected postoperatively was significantly lower in the TUERP group (13.98±10.01 liter versus 24.73±21.90 liter; p=0.04). No statistically significant differences were noted between the two groups in terms of the postoperative IPSS, QoL, Q max, PSA, postoperative Hct, and the length of hospital stay. Conclusion: The present study compared the surgical outcomes between the TUERP and the TURP techniques performed in medium prostate sizes. The authors concluded that TUERP resulted in a greater prostate tissue removal and, importantly, better intraoperative bleeding control. Keywords: Benign Prostatic Hyperplasia, Transurethral enucleation of the prostate

scholarly journals Drain verus No Drain After Thyroidectomy: A Preliminary Prospective Randomized Controlled Trial

2014 ◽  
Vol 29 (1) ◽  
pp. 11-15
Author(s):  
Jefferson A. Alamani ◽  
Elias T. Reala ◽  
Samantha S. Castañeda ◽  
Antonio H. Chua
Keyword(s):  
Hospital Stay ◽  
Prevention And Control ◽  
Controlled Trial ◽  
Length Of Hospital Stay ◽  
Wound Dehiscence ◽  
Randomized Controlled ◽  
Prospective Randomized Controlled Trial ◽  
Drain Group ◽  
The Mean ◽  
And Control

Objective: To evaluate the necessity of placing a drain in post-thyroidectomy patients, we aimed to determine whether insertion of a passive drain, as compared to no drain, in post-thyroidectomy patients, would significantly affect hematoma formation, wound infection, wound dehiscence and length of hospital stay. Methods: Study Design:            Prospective randomized controlled trial Setting:                       Tertiary government training hospital Subjects:                     Patients who underwent thyroidectomy for various thyroid pathologies were divided into two postoperative treatment arms: one group with insertion of a passive drain, and another group without a drain. Hematoma, wound infection, wound dehiscence, and length of hospital stay were the outcomes measured per treatment arm.   Results: A total of 66 patients were evaluated. There were 54 females (81.81%) and 12 males (18.18%). The mean age for the drain group was 44.88 years and 43.67 years for the no drain group. Four patients developed complications in the drain group and 2 developed complications in the no drain group. The rate of complications between both groups was not statistically significant.  The mean hospital stay of the drain group was 3.15 days, which in the no drain group was 2.51 days. The difference in length of hospital stay was statistically significant.   Conclusion:   There was no difference in the development of complications among the drain and no drain group. Thyroidectomy without surgical drains was associated with a significant reduction in hospital stay compared to thyroidectomy with routine placement of drains.   Keywords: Surgical drainage / methods, hematoma / prevention and control, postoperative complications / prevention and control, thyroid disease / surgery, thyroidectomy / methods  

Modifield Desarda Repair and Hernioplastia Lichtenstein Repair for Inguinal Hernia

2021 ◽  
Vol 2 (3) ◽  
pp. 01-05
Author(s):  
Pedro Rolando Lòpez Rodrìguez ◽  
Eduardo Garcia Castillo ◽  
Olga Caridad Leòn Gonzàlez ◽  
Jorge Agustin Satorre Rocha ◽  
Luis Marrero Quiala ◽  
...  
Keyword(s):  
Inguinal Hernia ◽  
Operative Time ◽  
Controlled Trial ◽  
Operation Time ◽  
Lichtenstein Repair ◽  
Prospective Randomized Controlled Trial ◽  
The Mean ◽  
Group 2 ◽  
Location Type ◽  
Mean Time

Introduction: The objective of this study is to compare the outcomes of Modified Desarda repair no mesh and Lichtenstein repair for inguinal hernia. Methods: This is a prospective randomized controlled trial study of 1342 patients having 1394 hernias operated from January 2008 to December 2020. 690 patients were operated using Lichtenstein repair and 652 using Desarda repair. The demographie data (Age,Sex) , hernia type and location , anesthetic , operative time , postoperative pain and complications were analysed. Results: There were no significant differences regarding age, sex, location, type of hernia, and pain in both the groups. The operation time was 52 minutes in Modified Desarda group and 42 minutes in the Lichtenstein group that is significant (p<0.05). The recurrence was 0.0 % in Modified Desarda group and 0.28 % in Lichtenstein group. But, there were 9 cases of infection to the polypropylene mesh in the Lichtenstein group, 2 of this required re-exploration. The morbidity was also significantly more in Lichtenstein group (7,6 %) as compared to Modified Desarda group (3.8 %). The mean time to return to work in the Modified Desarda group was 8.26 days while a mean of 12.58 days was in the Lichtenstein group. The mean hospital stay was 29 hrs. in Modified Desarda group while it was 49 hours in the Lichtenstein group in those patients who were hospitalized. Conclusions: The modified Desarda repair scores significantly on Lichtenstein repair in most of all aspects, including reexplorations and morbidity. Modified Desarda repair is a better option compared to Lichtenstein repair.

Breast reduction with the posterosuperior pedicle: a series of 200 consecutive patients

Folia Medica ◽  
2011 ◽  
Vol 53 (4) ◽  
pp. 34-41 ◽  
Author(s):  
Hristo Shipkov ◽  
Ali Mojallal ◽  
Fabienne Braye
Keyword(s):  
Breast Reduction ◽  
Average Length ◽  
Length Of Hospital Stay ◽  
Vascular Supply ◽  
Average Weight ◽  
Superior Pedicle ◽  
Areola Complex ◽  
Junction Site ◽  
Duration Of Surgery ◽  
The Mean

ABSTRACT AIM: To present and evaluate the outcomes of the posterosuperior pedicle breast reduction technique. PATIENTS AND METHODS: 200 patients were included in the present retrospective study. They were operated on between January 2006 and January 2009. The mean age was 35.9 years (range 22 to 58 years). The average notch-to-nipple distance was 35.8 cm (range, 29 to 42 cm). The mean body mass index was 27 (range, 22 to 35 cm). Results were assessed by means of self-evaluation and by an independent 5-member jury. Fifty two patients (26%) had had bariatric surgery and 48 (24%) had had abdominoplasty. None of the patients had any previous breast surgery. All patients reported dorsal and cervical pain. RESULTS: The mean follow-up period was 16 months (range, 13 to 23 months). The average weight resected was 981 g (range from 370 g to 1800 g). The average duration of surgery was 2h (range, 1.50 to 2.30 hours) and average length of hospital stay was 2.3 days (range, 2 to 4 days). The duration of the outpatient postoperative care until complete wound healing was 15.2 days (range, 13 to 20 days). There were 4 major complications (2%) (1 bilateral and 3 unilateral infections) treated by drainage and intravenous antibiotics. Twenty-two minor complications were recorded (11%) including one desquamation of the nipple-areola complex without necrosis (0.5%) delayed healing at the junction site of the inverted T incision in 21 cases (10.5%). One hundred and forty eight patients evaluated their results as “very good” (74%), 36 as “good” (18%), and 16 as “acceptable” (8%). There were no results assessed as “poor.” Fifty-eight percent of the patients found that back pain had totally resolved versus 42% who had signifi cant improvement though not complete resolution. CONCLUSIONS: The postero-superior pedicle for breast reduction is a reproducible and versatile technique. The preservation of the anterior intercostal artery perforators enhances the reliability of the vascular supply to the superior pedicle.

Randomised controlled trial of a prognostic assessment and management pathway to reduce the length of hospital stay in normotensive patients with acute pulmonary embolism

2021 ◽  
pp. 2100412
Author(s):  
David Jiménez ◽  
Carmen Rodríguez ◽  
Francisco León ◽  
Luis Jara-Palomares ◽  
Raquel López-Reyes ◽  
...  
Keyword(s):  
Acute Pulmonary Embolism ◽  
Controlled Trial ◽  
Intervention Group ◽  
Length Of Hospital Stay ◽  
Control Group ◽  
Prognostic Assessment ◽  
Prognostic Tests ◽  
The Mean ◽  
Randomised Controlled ◽  
Acute Pe

BackgroundThe length of hospital stay (LOS) for acute pulmonary embolism (PE) varies considerably. Whether the upfront use of a PE prognostic assessment and management pathway is effective in reducing the LOS remains unknown.MethodsWe conducted a randomised, controlled trial of adults hospitalised for acute PE: patients were assigned to a prognostic assessment and management pathway involving risk stratification, followed by predefined criteria for mobilisation and discharge (intervention group), or usual care (control group). The primary end point was LOS. The secondary end points were the cost of prognostic tests and of hospitalisation, and 30-day clinical outcomes.ResultsOf 500 patients who underwent randomisation, 498 were included in the modified intention-to-treat analysis. The median LOS was 4.0 days (interquartile range [IQR], 3.7 to 4.2 days) in the intervention group and 6.1 days (IQR, 5.7 to 6.5 days) in the control group (p<0.001). The mean total cost of prognostic tests was €174.76 in the intervention group, as compared with €233.12 in the control group (mean difference, €−58.37; 95% confidence interval [CI], €−84.34 to €−32.40). The mean total hospitalisation cost per patient was €2085.66 in the intervention group, compared with €3232.97 in the control group (mean difference, €−1147.31; 95% CI, €−1414.97 to €−879.65). No significant differences were observed in 30-day readmissions (4.0% versus 4.8%, respectively), or all-cause (2.4% versus 2.0%) and PE-related mortality rates (0.8% versus 1.2%).ConclusionsThe use of a prognostic assessment and management pathway was effective in reducing the LOS for acute PE.

Sign in / Sign up

Export Citation Format

Share Document